BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37398684)

  • 1. Left-sided valvular heart disease in dialysis recipients: a single-centre observational study.
    Elewa M; Mitra S; Jayanti A
    Clin Kidney J; 2023 Jul; 16(7):1092-1101. PubMed ID: 37398684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left-sided heart disease and risk of death in patients with end-stage kidney disease receiving haemodialysis: an observational study.
    Axelsson Raja A; Warming PE; Nielsen TL; Plesner LL; Ersbøll M; Dalsgaard M; Schou M; Rydahl C; Brandi L; Iversen K
    BMC Nephrol; 2020 Sep; 21(1):413. PubMed ID: 32977752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.
    Iung B; Delgado V; Rosenhek R; Price S; Prendergast B; Wendler O; De Bonis M; Tribouilloy C; Evangelista A; Bogachev-Prokophiev A; Apor A; Ince H; Laroche C; Popescu BA; Piérard L; Haude M; Hindricks G; Ruschitzka F; Windecker S; Bax JJ; Maggioni A; Vahanian A;
    Circulation; 2019 Oct; 140(14):1156-1169. PubMed ID: 31510787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey.
    Tribouilloy C; Bohbot Y; Kubala M; Ruschitzka F; Popescu B; Wendler O; Laroche C; Bartha E; Ince H; Simkova I; Vahanian A; Iung B
    Eur Heart J; 2022 Aug; 43(29):2756-2766. PubMed ID: 35511056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-Analysis Global Group in Chronic Heart Failure score for the prediction of mortality in valvular heart disease.
    Lv J; Xu H; Ye Y; Li Z; Wang W; Zhang B; Zhao Q; Zhang H; Zhao Z; Liu Q; Wang B; Duan Z; Yu Z; Guo S; Zhao Y; Gao R; Ge J; Wu Y;
    ESC Heart Fail; 2024 Feb; 11(1):349-365. PubMed ID: 38012105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and Prognosis of Patients With Nonvalvular Atrial Fibrillation and Significant Valvular Heart Disease Referred for Electrical Cardioversion.
    Vo NM; Leung M; van Rosendael PJ; Goedemans L; van Wijngaarden SE; Prihadi EA; van der Bijl P; Ajmone Marsan N; Delgado V; Bax JJ
    Am J Cardiol; 2020 Aug; 128():84-91. PubMed ID: 32650929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between valvular structure and biochemical indices of non-valvular atrial fibrillation and senile degenerative valvular heart disease.
    Chen JQ; Zeng X; Li KC; Huang JL; Guo BL; Zhou X
    J Thorac Dis; 2023 Feb; 15(2):611-619. PubMed ID: 36910075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival of people with valvular heart disease in a large, English community-based cohort study.
    Taylor CJ; Ordóñez-Mena JM; Jones NR; Roalfe AK; Myerson SG; Prendergast BD; Hobbs FR
    Heart; 2021 Aug; 107(16):1336-1343. PubMed ID: 34031157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution, Characteristics, and Management of Older Patients With Valvular Heart Disease in China: China-DVD Study.
    Xu H; Liu Q; Cao K; Ye Y; Zhang B; Li Z; Hao J; Qi X; Zhao Q; Liu S; Gao R; Wu Y;
    JACC Asia; 2022 Jun; 2(3):354-365. PubMed ID: 36338396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of Bioprosthetic Aortic Valve Degeneration.
    Nitsche C; Kammerlander AA; Knechtelsdorfer K; Kraiger JA; Goliasch G; Dona C; Schachner L; Öztürk B; Binder C; Duca F; Aschauer S; Zimpfer D; Bonderman D; Hengstenberg C; Mascherbauer J
    JACC Cardiovasc Imaging; 2020 Feb; 13(2 Pt 1):345-353. PubMed ID: 30878425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Mitral and Aortic Valvular Disease and Left Ventricular Dysfunction in a Lebanese Population: Retrospective Single-Center Experience.
    Nader V; Matta A; Canitrot R; Itier R; Salameh P; Lairez O; Elbaz M; Galinier M; Azar R; Roncalli J
    Med Sci Monit; 2021 Feb; 27():e928218. PubMed ID: 33558450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between cardiac valvular calcification and myocardial ischemia in asymptomatic high-risk patients with end-stage renal disease.
    Choi MJ; Kim JK; Kim SG; Kim SE; Kim SJ; Kim HJ; Song YR
    Atherosclerosis; 2013 Aug; 229(2):369-73. PubMed ID: 23880189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and Factors Associated with Left Ventricular Systolic Dysfunction in End-Stage Renal Disease Patients on Dialysis.
    Chinprateep B; Ratanasit N; Chanchairujira T
    J Med Assoc Thai; 2016 Jun; 99(6):653-8. PubMed ID: 29900724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome and undertreatment of mitral regurgitation: a community cohort study.
    Dziadzko V; Clavel MA; Dziadzko M; Medina-Inojosa JR; Michelena H; Maalouf J; Nkomo V; Thapa P; Enriquez-Sarano M
    Lancet; 2018 Mar; 391(10124):960-969. PubMed ID: 29536860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial.
    De Caterina R; Renda G; Carnicelli AP; Nordio F; Trevisan M; Mercuri MF; Ruff CT; Antman EM; Braunwald E; Giugliano RP
    J Am Coll Cardiol; 2017 Mar; 69(11):1372-1382. PubMed ID: 28302288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospitalized valvular heart disease in patients on renal transplant waiting list: incidence, clinical correlates and outcomes.
    Abbott KC; Hshieh P; Cruess D; Agodoa LY; Welch PG; Taylor AJ; Yuan CM
    Clin Nephrol; 2003 Feb; 59(2):79-87. PubMed ID: 12608550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of cardio-renal-hepatic function in patients with valvular heart disease: a multi-biomarker approach-the cardio-renal-hepatic score.
    Lv J; Zhang B; Ye Y; Li Z; Wang W; Zhao Q; Liu Q; Zhao Z; Zhang H; Wang B; Yu Z; Duan Z; Guo S; Zhao Y; Gao R; Xu H; Wu Y;
    BMC Med; 2023 Jul; 21(1):257. PubMed ID: 37455313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide in Elderly Patients With Valvular Heart Disease.
    Zhang B; Xu H; Zhang H; Liu Q; Ye Y; Hao J; Zhao Q; Qi X; Liu S; Zhang E; Xu Y; Gao R; Pibarot P; Clavel MA; Wu Y;
    J Am Coll Cardiol; 2020 Apr; 75(14):1659-1672. PubMed ID: 32273031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Valvular Heart Disease on Mortality, Thromboembolic and Cardiac Events in Japanese Patients With Atrial Fibrillation - The Fushimi AF Registry.
    Doi K; Ogawa H; Ishigami K; Ikeda S; Aono Y; Hamatani Y; Fujino A; An Y; Ishii M; Iguchi M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Akao M;
    Circ J; 2020 Apr; 84(5):714-722. PubMed ID: 32213725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of asymptomatic valvular heart disease in the elderly population: a community-based echocardiographic study.
    Tsampasian V; Militaru C; Parasuraman SK; Loudon BL; Lowery C; Rudd A; Srinivasan J; Singh S; Dwivedi G; Mahadavan G; Dawson D; Clark A; Vassiliou VS; Frenneaux MP
    Eur Heart J Cardiovasc Imaging; 2024 Jun; ():. PubMed ID: 38925103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.